- Home
- MCW vs TSHA Comparison
MCW vs TSHA Comparison
Compare MCW & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCW | TSHA |
|---|---|---|
| Founded | 1996 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MCW | TSHA |
|---|---|---|
| Price | $5.24 | $5.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $7.68 | ★ $10.22 |
| AVG Volume (30 Days) | 1.3M | ★ 3.5M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.84 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $1,041,660,000.00 | $6,310,000.00 |
| Revenue This Year | $6.86 | N/A |
| Revenue Next Year | $6.87 | N/A |
| P/E Ratio | $19.42 | ★ N/A |
| Revenue Growth | ★ 6.98 | N/A |
| 52 Week Low | $4.61 | $1.05 |
| 52 Week High | $8.60 | $5.51 |
Technical Indicators
Market Signals| Indicator | MCW | TSHA |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 60.49 |
| Support Level | $5.19 | $4.03 |
| Resistance Level | $5.35 | $4.92 |
| Average True Range (ATR) | 0.17 | 0.29 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 68.22 | 84.91 |
Price Performance
Historical ComparisonAbout MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.